MAP7 and breast carcinoma: MAP7 has been shown to be highly in breast cancer and cervical cancer, where it enhances the invasion and migration of breast cancer and cervical cancer cells (Zhang et al., 2020; Wang et al., 2022; Wang et al., 2023).